Dyselectrolytemia, especially hyponatremia is a common occurrence in hospitalized patients, and a number of dreaded complications arise out of the disorder itself and its treatment. Osmotic demyelination syndrome develops secondary to rapid correction of hyponatremia. As the disease is rare and available literature from Intensive Care Units are limited, we report our retrospective observation over 5 years. Overall incidence was 2.5% with altered sensorium and hypokalemia as most common symptom and associated factor respectively. Isolated pontine involvement was in 41% and combined pontine, and extra-pontine lesions were found in 23% of cases. All patients received supportive therapy; out of which 2 died and complete neurological recovery was seen in 24% of patients. Our findings suggest that a well organized supportive therapy and multidisciplinary approach is of more concern than many available therapeutic modalities which are still to be proved..
Introduction
Osmotic demyelination syndrome (ODS) is a rare clinical entity which involves both pontine and extra-pontine myelinolysis (EPM). [1] Although, it can occur in the presence of varied etiological factors, [2, 3] the primary pathophysiology described being either a reduced adaptive capacity of the neuroglia to large shifts in the serum osmolarity [4] or the cellular edema caused by fluctuations in electrolyte forces results in compression and subsequent demyelination of fiber tracts. [5] The outcome of the clinical entity is very dramatic ranging from the vegetative state to full neurological recovery. [2, [6] [7] [8] Various case reports of ODS have been published from time to time with few case series out of which the largest being one studied in 58 patients. [9] Though, the exact incidence of ODS is not known, an autopsy based study documented a prevalence rate of 0.25-0.5% in the general population [7] and 10% in patients undergoing liver transplantation. [7, 10] Being a rare disease with variable, but preventable outcome, the present study was performed with an aim to enrich the present understanding of the disease course, especially in Intensive Care Unit (ICU) patients.
Subjects and Methods
After approval from the institutional ethical committee, we retrospectively collected data and analyzed all patients admitted to our ICU with a diagnosis of ODS in the last 5 years (July' 2008 -July' 2013). Computerized database and patient records were used for data collection and analysis.
Results
Of a total of 665 patients admitted in ICU during this period, 17 (2.5%) patients (11 male and 6 female) with a mean age of 32 years (12-78 years) were diagnosed as having ODS. Three patients developed ODS during their ICU stay, whereas the rest were transferred to the ICU from different areas of the hospital and outside. Out of the total 17 patients, seven had hyponatremia, followed by rapid correction. Two patients required imaging twice as initial computerized tomography (CT) scan for altered sensorium was essentially normal and later on magnetic resonance imaging (MRI) revealed ODS. Neurological 
Discussion
In the present analysis, we found an ODS incidence of 2.5% over 5 years. Altered sensorium was found to be the most common symptom and hypokalemia as the most common underlying associated factor. MRI findings revealed isolated pontine involvement in 41%, both pontine and extra-pontine involvement in 23% of the cases. All the patients received supportive therapy; of these 17 patients complete neurological recovery occurred in 24% of the patients.
True incidence of ODS is unknown until date. In a study of 3000 brains examined postmortem, there were 15 cases of asymptomatic central pontine myelinolysis (CPM). [11] We evidenced an incidence of 2.5% in our ICU with a reported 12% mortality.
Associated factors
Literature evidence speaks in favor of many associated factors like syndrome of inappropriate antidiuretic hormone, burns, chronic alcoholism, malnutrition, psychogenic polydipsia, liver transplantation, dialysis, hyperemesis gravidarum etc., which predispose one to develop ODS. [12] The most common associated factor seen in this study was severe hypokalemia defined as serum potassium level ≤1.5 mEq/L (41%), followed closely by chronic alcoholism, prolonged diuretic therapy and postoperative fluid therapy each approximately seen in 30% of the cases. In a similar review, Lampl and Yazdi found alcoholism in 40% and liver transplantation in 17% of the cases of ODS. [10] Almost all patients with chronic diuretic therapy had dyselectrolytemia, whereas more than half (4 out of 7) of those having severe hypokalemia had a history of diuretic therapy.
The general background which might add to the ease of development of ODS in these sub-group of patients is a disordered state of solute metabolism or a general deficiency of organic osmolytes. This in itself predisposes cells to undergo a change in size and volume, thus makes prone for cell shrinkage. [11, 12] 
Clinical presentation
The classical picture is a patient who presented with seizures and altered sensorium due to hyponatremia, had a rapid recovery with normalization of serum sodium, but only to deteriorate again. This second phase correlates with a rapid correction of serum sodium levels and development of ODS. [2] The clinical picture is usually very wide depending upon the area in the central nervous system involved with demyelination. When pons along with corticobulbar and corticospinal tracts are involved, the classical presentation is dysarthria and dysphagia along with flaccid paralysis changing over to spastic later on. EPM is characterized by tremor, ataxia and movement disorders like mutism, Parkinsonism, dystonia, and catatonia. [11] If the lesion extends further, then it may result in pupillary, oculomotor dysfunction, and locked-in syndrome. When there is a combination of pontine and extra-pontine lesions, the clinical picture is usually mixed and variable. [2] It has been documented that ODS has a peak incidence in adults with a male preponderance, possibly due to the association of risk factors like alcoholism in the particular age group. [10] We observed a similar male preponderance (64%) and none of the patients in this study belong to pediatric age range.
In this case series, out of 17 patients, 11 (64%) had altered sensorium as the most common clinical presentation while only 3 (17%) had episodes of seizures. Flaccid quadriparesis was seen in 6 patients (35%) and surprisingly, 64% of the patients had normal muscular tone.
Radiology and osmotic demyelination syndrome
Radiology plays a major role in the diagnosis of ODS. Not only it provides support to the clinical suspicion, it helps in excluding other possibilities also.
Demyelination appears on CT as an area of decreased attenuation but unfortunately it may underestimate the true extent of the disease process. With greater sensitivity, MRI is the modality of choice, which speaks about the number and extent of lesions in both pontine and extra-pontine areas.
Acute demyelinating lesions are visible as symmetric and hypointense lesions on T1-weighted and hyperintense in T2-weighted images in the subacute phase. The usual picture appears as a tridents shaped area of hyperintense or hypointense lesion in the central pons with sparing of the ventrolateral pons and do not enhance with contrast. [12] Lesions on MRI may appear days to weeks after the onset of symptoms and these may or may not resolve even though there is partial or complete clinical recovery. [6, 8] Extra-pontine involvement occurs with or without CPM. In the present study, MRI revealed involvement of the central pons in 7 patients (41%), extra-pontine lesions in 6 (35%) and combined involvement in 4 (24%) patients. Similarly, Gocht and Colmant in their series of 58 cases, reported isolated CPM in about 50% of the cases, combined lesions in 30% of the cases and isolated EPM in about 20% of the cases. [9] 
Treatment and outcome
Once diagnosis is established, treatment is supportive. Reports on random case reports and small case series have found benefits of a multiply of treatment modalities such as steroids, intravenous immunoglobulin, and thyrotrophin releasing hormone, re-induction hyponatremia, administration of organic osmolytes (urea, Myoinositol), and dopaminergic compounds, especially in EPM cases etc. [2, 8] As there is no randomized human trial till date, all these possible therapies are not yet recommended in ODS patients. Abbott et al. in a study of 34 ODS patients reported a mortality of 6% whereas 30% completely recovered, 32% had some debilitating illness, but independent, and a similar number of patients were recovered but dependent. [11] Martin reported in their review an overall mortality of 40-50% in ODS and a lower rate in those subgroup of patients admitted in intensive therapy unit (10-20%). [2] In the present study of 17 patients, we observed complete neurological recovery in 24% of patients, recovery with some deficit in 47%, vegetative state in 18% of patients. The mortality in this study was 12% which corroborates with the findings of Martin in their subgroup of ICU patients. [2] Literature evidence varies widely with regards to mortality ranging from 6% to 90%. [6, 9] Whereas Menger and Jörg reported 40% of patients recovered without any noticeable neurologic sequelae. [6] One study had reported 25% of patients developed grave neurological outcome requiring lifelong support. [12] This study results reflect the true area of concern is not one of the available but unproven multiple modalities of therapy rather it requires a well-organized supportive therapy and multidisciplinary approach to have a better outcome. [6] In addition, the focus has to be preventive not therapeutic as ODS is not a disease in itself rather a complication.
